Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03352232 · ClinicalTrials.gov registry record · Early Phase 1

Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke

A Early Phase 1 study of Stroke and Ischemic Stroke, sponsored by Abington Memorial Hospital.

Completed
Registry status
Early Phase 1
Development phase
5
Enrollment target
1
Study location

NCT03352232 is a Early Phase 1 study of Stroke and Ischemic Stroke that has completed, run by Abington Memorial Hospital. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03352232, a Early Phase 1 study of Stroke and Ischemic Stroke, has completed, sponsored by Abington Memorial Hospital.

COMPLETED
Registry status
Early Phase 1
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

To study safety, feasibility and outcomes of combining osteopathic manipulative therapies with hyperbaric oxygen therapy in reducing the functional deficits in stroke survivors in subacute and chronic phases post ischemic stroke. To document the same as part of a pilot project in anticipation of further investigational studies.

Interventions

  • COMBINATION_PRODUCT HBOT and OMT

Study Locations (1)

Pennsylvania

  • Abington Memorial Hospital - Abington

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-02-03
Est. Completion 2021-07-19
Phase Early Phase 1

Sponsor

Abington Memorial Hospital

2 total trials

What the Registry Record Tells You About NCT03352232

The ClinicalTrials.gov registry entry for NCT03352232 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Abington Memorial Hospital, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which HBOT and OMT is the first listed.

NCT03352232 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03352232 about?

NCT03352232 is a clinical study titled "Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke". To study safety, feasibility and outcomes of combining osteopathic manipulative therapies with hyperbaric oxygen therapy in reducing the functional deficits in stroke survivors in subacute and chronic phases post ischemic stroke. To document the same as part of a pilot project in anticipation of fur...

What is the current status of trial NCT03352232?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2018-02-03. Estimated completion is 2021-07-19.

What conditions does trial NCT03352232 study?

This clinical trial studies the following conditions: Stroke, Ischemic Stroke, Chronic Stroke, Motor Dysfunction.

What interventions are being tested in trial NCT03352232?

The interventions under investigation include: HBOT and OMT (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT03352232?

This trial is sponsored by Abington Memorial Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03352232 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.